Prosecution Insights
Last updated: October 02, 2026

Examiner: SKROBARCZYK III, ROBERT ANTHONY

Tech Center 3700 • Art Units: 1651 3685 3783 3792 3796

This examiner grants 17% of resolved cases

Analysis

Robert Anthony Skrobarczyk III has resolved 18 cases in Art Unit 1651. The allowance rate is 16.7 percent. The interview lift is 16.3 percent. These figures indicate a challenging environment with a low probability of success, where interviews provide a boost roughly equal to the baseline allowance rate.

The median time to allowance is 973 days. While the pendency is relatively short, the 16.7 percent allowance rate suggests that obtaining a patent is difficult. Practitioners should be prepared for a high rate of rejection and consider the 16.3 percent interview lift as a necessary tool for advancing prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

16.7%
Allow Rate
-53.3% vs TC avg
52
Total Applications
+16.3%
Interview Lift
973
Avg Prosecution Days
Based on 18 resolved cases, 2023–2026

Rejection Statute Breakdown

21.0%
§101 Eligibility
21.7%
§102 Novelty
43.1%
§103 Obviousness
13.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18897235 CIRCULATION SUPPORT DEVICES, SYSTEMS, AND METHODS Non-Final OA Boston Scientific Scimed, Inc.
19033700 NEUROSTIMULATOR SYSTEMS WITH ACCELEROMETER USES Non-Final OA Boston Scientific Neuromodulation Corporation
17913718 CAREGIVER ASSISTANCE SYSTEM Final Rejection Stryker Corporation
18851794 ACTIVE CANCELLATION OF NOISE IN A MEDICAL DEVICE Non-Final OA KONINKLIJKE PHILIPS N.V.
18599917 COGNITIVE FUNCTION IMPROVEMENTS AND BIOMARKER-MODULATED DEEP BRAIN STIMULATION Final Rejection Mayo Foundation for Medical Education and Research
18736268 VITAL SIGN MONITOR, METHOD FOR OPERATING A VITAL SIGN MONITOR, AND METHOD FOR TRAINING A VITAL SIGN MONITOR Final Rejection ams-OSRAM AG
18856928 PACEMAKER AND OPERATION METHOD OF SUCH PACEMAKER Non-Final OA BIOTRONIK SE & CO. KG
18702038 Implantable Medical Device for Sensing Physiological Signals Final Rejection BIOTRONIK SE & Co. KG
18546641 EAR TEMPERATURE DATA PROCESSING METHOD AND ELECTRONIC DEVICE Final Rejection Honor Device Co., Ltd.
18094618 IMPLANTABLE CANCER THERAPY ELECTRODES WITH REDUCED MRI ARTIFACTS Final Rejection Cardiac Pacemakers, Inc.
18901448 METHOD AND SYSTEM FOR FUNCTIONAL AND STRUCTURAL REMODELING PROGRESSION IN ATRIAL FIBRILLATION Non-Final OA Northwestern University
18404041 DEVICES AND METHODS FOR LIGHT DELIVERY Non-Final OA NORTHWESTERN UNIVERSITY
18812881 BIOSTIMULATOR HAVING PACING EXTENSION Final Rejection Pacesetter, Inc.
18968145 SYSTEM AND METHOD OF NERVE STIMULATION UTILIZING THORACIC IMPEDANCE Non-Final OA The Alfred E. Mann Foundation for Scientific Research
18506808 LOGIC-BASED TYPING OF MULTIPLE SCLEROSIS SUBJECTS BASED ON CODED DATA Final Rejection HOFFMANN-LA ROCHE INC.
18639079 INLET GUARD FOR BLOOD PUMPS Final Rejection MAGENTA MEDICAL LTD
18639098 BEARING HOUSING FOR BLOOD PUMP Non-Final OA MAGENTA MEDICAL LTD
17383972 SYSTEMS WITH IMPLANTED CONDUIT TRACKING Final Rejection Nalu Medical, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month